BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33559768)

  • 1. Downstaging of cervical cancer in Tanzania over a 16-year period.
    Mattick LJ; Ochs-Balcom HM; Mwaiselage J; Kahesa C; Gard AC; Shalan F; Soliman AS
    Cancer Causes Control; 2021 Apr; 32(4):401-407. PubMed ID: 33559768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Most women diagnosed with cervical cancer by a visual screening program in Tanzania completed treatment: evidence from a retrospective cohort study.
    Gard AC; Soliman AS; Ngoma T; Mwaiselage J; Kahesa C; Chamberlain RM; Harlow SD
    BMC Public Health; 2014 Sep; 14():910. PubMed ID: 25187329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Screening and Treatment for Cervical Cancer in Tanzania: Implications for other Sub-Saharan African Countries.
    Nelson S; Kim J; Wilson FA; Soliman AS; Ngoma T; Kahesa C; Mwaiselage J
    Value Health Reg Issues; 2016 Sep; 10():1-6. PubMed ID: 27881270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the under-estimation of cervical Cancer in remote regions of Tanzania.
    Gesink MP; Chamberlain RM; Mwaiselage J; Kahesa C; Jackson K; Mueller W; Meza JL; Soliman AS
    BMC Cancer; 2020 Sep; 20(1):939. PubMed ID: 32998702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and geographic distribution of HIV-positive women diagnosed with cervical cancer in Dar es Salaam, Tanzania.
    Lovgren K; Soliman AS; Ngoma T; Kahesa C; Meza J
    Int J STD AIDS; 2016 Oct; 27(12):1049-1056. PubMed ID: 26464500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Return on Investment of a Breast Cancer Screening Program in Tanzania: Opportunity for Patient and Public Education.
    Heisler Z; Eastwood B; Mwaiselage J; Kahesa C; Msami K; Soliman AS
    J Cancer Educ; 2022 Jun; 37(3):701-708. PubMed ID: 32980979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of in-house pathology services on downstaging cervical cancer in Tanzania over an 18-year period.
    Fuss CG; Msami K; Kahesa C; Mwaiselage J; Gordon A; Sohler N; Mattick LJ; Soliman AS
    Cancer Causes Control; 2024 Jan; 35(1):93-101. PubMed ID: 37574489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Needs for Professional Education to Optimize Cervical Cancer Screenings in Low-Income Countries: a Case Study from Tanzania.
    Lavelle AE; Su D; Kahesa C; Soliman AS
    J Cancer Educ; 2019 Feb; 34(1):124-129. PubMed ID: 28895070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
    Bakiewicz A; Rasch V; Mwaiselage J; Linde DS
    BMC Womens Health; 2020 Mar; 20(1):65. PubMed ID: 32234028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lived experiences and caring needs of women diagnosed with cervical cancer: A qualitative study in Dar es Salaam, Tanzania.
    Chona EZ; Msengi EA; Gosse RA; Ambikile JS
    PLoS One; 2023; 18(8):e0289925. PubMed ID: 37561728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing needs: a qualitative study of cervical cancer screening attendance among HPV-positive women in Tanzania.
    Linde DS; Rasch V; Mwaiselage JD; Gammeltoft TM
    BMJ Open; 2019 Feb; 9(2):e024011. PubMed ID: 30819704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Initiating Screening Programs on Referral and Management of Cervical Cancer in Tanzania.
    Sedani A; Soliman AS; Msami K; Msemo D; Mwaiselage J; Schmid K; Kahesa C
    J Glob Oncol; 2019 Jul; 5():JGO1800052. PubMed ID: 31343933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the need of educational programs for cervical screening in rural Tanzania.
    Peters LM; Soliman AS; Bukori P; Mkuchu J; Ngoma T
    J Cancer Educ; 2010 Jun; 25(2):153-9. PubMed ID: 20204578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Screening in Low-Income Countries: A New Program for Downstaging Breast Cancer in Tanzania.
    Cherlin DS; Mwaiselage J; Msami K; Heisler Z; Young H; Cui Q; Soliman AS
    Biomed Res Int; 2022; 2022():9795534. PubMed ID: 35425839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for VIA positivity and determinants of screening attendances in Dar es Salaam, Tanzania.
    Kahesa C; Kjaer SK; Ngoma T; Mwaiselage J; Dartell M; Iftner T; Rasch V
    BMC Public Health; 2012 Dec; 12():1055. PubMed ID: 23216752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing Research Education Groups in African Cancer Centers: The Experience in Tanzania.
    Msami K; Mbwana M; Mwaiselage J; Nyagabona S; Makani J; Dharsee N; Kahesa C; Soliman AS
    J Cancer Educ; 2021 Jul; 36(Suppl 1):101-108. PubMed ID: 34128212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of acceptance of cervical cancer screening in Dar es Salaam, Tanzania.
    Kahesa C; Kjaer S; Mwaiselage J; Ngoma T; Tersbol B; Dartell M; Rasch V
    BMC Public Health; 2012 Dec; 12():1093. PubMed ID: 23253445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual inspection with acetic acid screening for cervical cancer among women receiving anti-retroviral therapy for human immunodeficiency virus infection in northern Tanzania.
    Chinn JO; Runge AS; Dinicu AI; Chang J; Maher JA; Crawford EW; Naaseh A; Cooper EC; Zezoff DC; White KM; Lucas AN; Bera KR; Bernstein M; Hari A; Ziogas A; Tewari SE; Pearre DC; Tewari KS
    J Obstet Gynaecol Res; 2021 Dec; 47(12):4365-4370. PubMed ID: 34614540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptance of peer navigators to reduce barriers to cervical cancer screening and treatment among women with HIV infection in Tanzania.
    Koneru A; Jolly PE; Blakemore S; McCree R; Lisovicz NF; Aris EA; Mtesigwa T; Yuma S; Mwaiselage JD
    Int J Gynaecol Obstet; 2017 Jul; 138(1):53-61. PubMed ID: 28391628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.